Related Experiment Video
Updated: Jun 8, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
A deep learning approach for rational ligand generation with toxicity control via reactive building blocks
Pengyong Li1, Kaihao Zhang2, Tianxiao Liu1
1School of Computer Science and Technology, Xidian University, Xi'an, China.
None:
Deep generative models are gaining attention in the field of de novo drug design. However, the rational design of ligand molecules for novel targets remains challenging, particularly in controlling the properties of the generated molecules. Here, inspired by the DNA-encoded compound library technique, we introduce DeepBlock, a deep learning approach for block-based ligand generation tailored to target protein sequences while enabling precise property control. DeepBlock neatly divides the generation process into two steps: building blocks generation and molecule reconstruction, accomplished by a neural network and a rule-based reconstruction algorithm we proposed, respectively. Furthermore, DeepBlock synergizes the optimization algorithm and deep learning to regulate the properties of the generated molecules. Experiments show that DeepBlock outperforms existing methods in generating ligands with affinity, synthetic accessibility and drug likeness. Moreover, when integrated with simulated annealing or Bayesian optimization using toxicity as the optimization objective, DeepBlock successfully generates ligands with low toxicity while preserving affinity with the target.
More Related Videos
Related Concept Videos
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Drug-Receptor Bonds
In...
Metal-Ligand Bonds
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
Drug Discovery: Overview
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with...

